Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announces that it has completed its previously announced acquisition of Robocath, an innovator of robotic technologies for interventional cardiology and neurointerventions. Robocath will now be fully integrated into Stereotaxis, combining complementary technologies and expertise to accelerate the development of next-generation robotic solutions for electrophysiology, interventional cardiology, and neurointerventions.
Read the full article: Stereotaxis Completes Acquisition of Robocath //
Source: https://www.globenewswire.com/news-release/2026/07/09/3324770/21634/en/stereotaxis-completes-acquisition-of-robocath.html